Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Griffith Donald J., Director. Insider active across 1 company, notably Sonnet BioTherapeutics Holdings, Inc.. In total, 6 reports have been published. History available since 25 May 2021. The latest transaction was filed on 25 May 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Griffith Donald J. serves as a Board Member at Sonnet BioTherapeutics Holdings, Inc. In this role, he contributes to governance and oversight of the company's activities, bringing his expertise in the biopharmaceutical sector.